According to a large-scale international joint consortium, it was shown that histopathological features of breast cancer refine the likelihood estimation for BRCA1 or BRCA2 variant status, which can be informative for genetic testing and clinical management of the patients involved [103]. The gene discussed is BRCA2; the disease is breast carcinoma.